Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.76
-0.50 (-4.44%)
At close: Aug 15, 2025, 3:59 PM
10.78
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-20.59M -7.21M -13.56M
Depreciation & Amortization
16K 97K 110K
Stock-Based Compensation
439K 313K 412K
Other Working Capital
775K -857K -1.34M
Other Non-Cash Items
473K 1.05M 3.81M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
1.57M -81K -1.31M
Operating Cash Flow
-18.09M -5.82M -10.54M
Capital Expenditures
-109K n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-11.89M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a -1M
Investing Cash Flow
-12M n/a -1M
Debt Repayment
n/a n/a -1M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-3.34M n/a 1M
Financial Cash Flow
81.99M n/a 225K
Net Cash Flow
51.91M -5.82M -11.32M
Free Cash Flow
-18.2M -5.82M -10.54M